407 related articles for article (PubMed ID: 18073512)
1. Cannabinoid system and neuroinflammation: implications for multiple sclerosis.
Correa F; Docagne F; Mestre L; Loría F; Hernangómez M; Borrell J; Guaza C
Neuroimmunomodulation; 2007; 14(3-4):182-7. PubMed ID: 18073512
[TBL] [Abstract][Full Text] [Related]
2. [Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis].
Mestre L; Correa F; Docagne F; Clemente D; Ortega-Gutiérrez S; Arévalo-Martín A; Molina-Holgado E; Borrell J; Guaza C
Rev Neurol; 2006 Nov 1-15; 43(9):541-8. PubMed ID: 17072810
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptors in microglia of the central nervous system: immune functional relevance.
Cabral GA; Marciano-Cabral F
J Leukoc Biol; 2005 Dec; 78(6):1192-7. PubMed ID: 16204639
[TBL] [Abstract][Full Text] [Related]
4. Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.
Loría F; Petrosino S; Mestre L; Spagnolo A; Correa F; Hernangómez M; Guaza C; Di Marzo V; Docagne F
Eur J Neurosci; 2008 Aug; 28(4):633-41. PubMed ID: 18657182
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid influence on cytokine profile in multiple sclerosis.
Katona S; Kaminski E; Sanders H; Zajicek J
Clin Exp Immunol; 2005 Jun; 140(3):580-5. PubMed ID: 15932522
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
Facchinetti F; Del Giudice E; Furegato S; Passarotto M; Leon A
Glia; 2003 Jan; 41(2):161-8. PubMed ID: 12509806
[TBL] [Abstract][Full Text] [Related]
7. The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation.
Correa F; Mestre L; Molina-Holgado E; Arévalo-Martín A; Docagne F; Romero E; Molina-Holgado F; Borrell J; Guaza C
Mini Rev Med Chem; 2005 Jul; 5(7):671-5. PubMed ID: 16026313
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective agents: cannabinoids.
Sánchez AJ; García-Merino A
Clin Immunol; 2012 Jan; 142(1):57-67. PubMed ID: 21420365
[TBL] [Abstract][Full Text] [Related]
9. The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages.
Tolón RM; Núñez E; Pazos MR; Benito C; Castillo AI; Martínez-Orgado JA; Romero J
Brain Res; 2009 Aug; 1283():148-54. PubMed ID: 19505450
[TBL] [Abstract][Full Text] [Related]
10. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids and the immune system: an overview.
Tanasescu R; Constantinescu CS
Immunobiology; 2010 Aug; 215(8):588-97. PubMed ID: 20153077
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease.
O'Sullivan SE; Kendall DA
Immunobiology; 2010 Aug; 215(8):611-6. PubMed ID: 19833407
[TBL] [Abstract][Full Text] [Related]
13. PPARgamma as a therapeutic target in central nervous system diseases.
Sundararajan S; Jiang Q; Heneka M; Landreth G
Neurochem Int; 2006 Jul; 49(2):136-44. PubMed ID: 16766086
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids: potential targets for bladder dysfunction.
Ruggieri MR
Handb Exp Pharmacol; 2011; (202):425-51. PubMed ID: 21290238
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.
Rossi S; Bernardi G; Centonze D
Exp Neurol; 2010 Jul; 224(1):92-102. PubMed ID: 20353778
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?
Croxford JL; Yamamura T
J Neuroimmunol; 2005 Sep; 166(1-2):3-18. PubMed ID: 16023222
[TBL] [Abstract][Full Text] [Related]
17. [The role of endocannabinoid system in physiological and pathological processes in the eye].
Nadolska K; Goś R
Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid signalling in the enteric nervous system.
Galligan JJ
Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids as potential anti-epileptic drugs.
Smith PF
Curr Opin Investig Drugs; 2005 Jul; 6(7):680-5. PubMed ID: 16044663
[TBL] [Abstract][Full Text] [Related]
20. Basic neuroanatomy and neuropharmacology of cannabinoids.
Breivogel CS; Sim-Selley LJ
Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
